Skip to main content
Premium Trial:

Request an Annual Quote

IBBL Receives ISO Certification

NEW YORK (GenomeWeb) – The Integrated BioBank of Luxembourg today announced it has received ISO 9001 certification from the European Society for Certification of Management Systems.

IBBL is now certified for the acquisition, validation, processing, storage, administration, and distribution of biological material to public or private end users. The independent, non-profit biobank also received NF S96-900 certification, the French standard for management of biological resources.

The certifications "will increase the biobank's visibility and reputation beyond the borders of Luxembourg," IBBL CEO Catherine Larue said. "The next step will be accreditation to ISO17025, the international norm for the requirements for the competence of testing laboratories."

Earlier this year, IBBL signed a performance contract with Luxembourg's Ministry of Higher Education and Research that will run until 2017. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.